Asymmetric dimethylarginine
|
Basic information |
| Metabolite name | Asymmetric dimethylarginine |
 | HMDB0001539 |
 |
C03626 |
 |
123831 |
| Synonyms | ADMA; |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | Asymmetric dimethylarginine |
| HMDB0001539 |
|
C03626 |
|
123831 |
| Synonyms | ADMA; |
| No. of studies | 10 |
|
Relationship between Asymmetric dimethylarginine and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1045 | Type1 | anxiety and depression group vs. control group | Plasma | Human | Up |
| Study M1135 | Type1 | PSD group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M1135 | Type2 | PSD + electroacupuncture group vs. PSD group | Faece | Sprague-Dawley rat | Up |
| Study M1142 | Type2 | MDD group, after intermittent theta burst stimulation vs. baseline | Plasma | Human | Up |
| Study M196 | Type1 | depression group vs. control group | Plasma | Human | Up |
| Study M458 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M683 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
| Study M683 | Type2 | CUMS + middle dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M683 | Type2 | CUMS + high dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
| Study M712 | Type1 | depression group vs. control group | Hippocampus | Cynomolgus monkey | Up |
| Study M772 | Type1 | CUMS group vs. control group | Amygdala | Sprague-Dawley rat | Down |
| Study M839 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M908 | Type3 | post-ketamine treatment vs. baseline | Plasma | Human | Down |